Form 20-F BioNTech SE For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20240320/APVZB22CZ22FD2Z2222G22ZLQBCBZZ229E62
Filed on: March 20, 2024
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Downgrades BioNTech (BNTX) to Market Perform
- Leyden Labs Reports Positive Phase 1 Results for RIG-101, Supporting Advancement into Phase 2 to Protect Asthma Patients
- Pharming Group to participate in September investor conferences
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
